HE-2300

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameHE-2300
Drug Alias NameHE-2300
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsObesityCentral Nervous System DiseasesCommunicable Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHarbor Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHarbor Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsObesityCentral Nervous System DiseasesCommunicable Diseases

Other Information

ATC CodeN/A
Related LinksN/A